Below are the most recent publications written about "Ruthenium" by people in Profiles.
-
Gouveia J?nior FS, Silveira JAM, Holanda TM, Marinho AD, Ridnour LA, Wink DA, de Siqueira RJB, Monteiro HSA, Sousa EHS, Lopes LGF. New nitrosyl ruthenium complexes with combined activities for multiple cardiovascular disorders. Dalton Trans. 2023 Apr 25; 52(16):5176-5191.
-
Elie BT, Hubbard K, Pechenyy Y, Layek B, Prabha S, Contel M. Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma. Cancer Med. 2019 08; 8(9):4304-4314.
-
Iniguez E, Varela-Ramirez A, Mart?nez A, Torres CL, S?nchez-Delgado RA, Maldonado RA. Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis. Acta Trop. 2016 Dec; 164:402-410.
-
Li H, Wu J, Melnyczuk JM, Olubi O, Lewis LI, Cao Y, Nagappan P, Khan SA, Ingram CW, Harruna II. Nano-Snowflower of Gold Nanoparticles-Ruthenium Metallopolymer-Carbon Nanotubes Binding Anti-DNP IgE Antibody. J Nanosci Nanotechnol. 2015 Aug; 15(8):5733-40.
-
Frik M, Mart?nez A, Elie BT, Gonzalo O, Ram?rez de Mingo D, Sana? M, S?nchez-Delgado R, Sadhukha T, Prabha S, Ramos JW, Marzo I, Contel M. In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer. J Med Chem. 2014 Dec 11; 57(23):9995-10012.
-
Medley J, Payne G, Banerjee HN, Giri D, Winstead A, Wachira JM, Krause JA, Shaw R, Pramanik SK, Mandal SK. DNA-binding and cytotoxic efficacy studies of organorhenium pentylcarbonate compounds. Mol Cell Biochem. 2015 Jan; 398(1-2):21-30.
-
Robles-Escajeda E, Mart?nez A, Varela-Ramirez A, S?nchez-Delgado RA, Aguilera RJ. Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells. Cell Biol Toxicol. 2013 Dec; 29(6):431-43.
-
Iniguez E, S?nchez A, Vasquez MA, Mart?nez A, Olivas J, Sattler A, S?nchez-Delgado RA, Maldonado RA. Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells. J Biol Inorg Chem. 2013 Oct; 18(7):779-90.
-
Mart?nez A, Carreon T, Iniguez E, Anzellotti A, S?nchez A, Tyan M, Sattler A, Herrera L, Maldonado RA, S?nchez-Delgado RA. Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells. J Med Chem. 2012 Apr 26; 55(8):3867-77.
-
Lakshman MK, Deb AC, Chamala RR, Pradhan P, Pratap R. Direct arylation of 6-phenylpurine and 6-arylpurine nucleosides by ruthenium-catalyzed C-H bond activation. Angew Chem Int Ed Engl. 2011 Nov 25; 50(48):11400-4.